MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy

NCT00027781 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

NETWORK

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: sabarubicin

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC